Intal (sodium cromoglycate) therapy in ulcerative colitis. 1977

J Malolepszy, and K Kuczymska-Sekieta, and W Chachaj

Intal was applied intrarectally for the treatment of ulcerative colitis in 39 patients with active pathological process. The drug was insufflated by means of rectoscopic tube at the dosage of 200 mg capsules daily for 15 days. Complete remission of the disease has been achieved in 97 per cent of patients within 2 weeks of the administration of the drug. As a maintenance treatment the patients were given SCG orally (240 mg daily) for a period of 2--3 years. During the course of 2--3 years' observation 93 per cent of patients have been maintained in remission by oral SCG therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012007 Rectum The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL. Rectums
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

J Malolepszy, and K Kuczymska-Sekieta, and W Chachaj
March 1979, Polski tygodnik lekarski (Warsaw, Poland : 1960),
J Malolepszy, and K Kuczymska-Sekieta, and W Chachaj
January 1982, British medical journal (Clinical research ed.),
J Malolepszy, and K Kuczymska-Sekieta, and W Chachaj
January 1977, Przeglad lekarski,
J Malolepszy, and K Kuczymska-Sekieta, and W Chachaj
January 1972, The Medical journal of Australia,
J Malolepszy, and K Kuczymska-Sekieta, and W Chachaj
October 1971, The Medical journal of Australia,
J Malolepszy, and K Kuczymska-Sekieta, and W Chachaj
December 1971, The Medical journal of Australia,
J Malolepszy, and K Kuczymska-Sekieta, and W Chachaj
November 1971, The Medical journal of Australia,
J Malolepszy, and K Kuczymska-Sekieta, and W Chachaj
January 1970, Advances in drug research,
J Malolepszy, and K Kuczymska-Sekieta, and W Chachaj
July 1978, The Medical journal of Australia,
J Malolepszy, and K Kuczymska-Sekieta, and W Chachaj
January 1981, Otolaryngologia polska = The Polish otolaryngology,
Copied contents to your clipboard!